The PreGen Research Program: Implementing Prenatal Genomic Testing in Australia—A Commentary
Australian and New Zealand Journal of Obstetrics and Gynaecology · 2025
DOI: 10.1111/ajo.13936 ↗Kurz gefasst
Fachartikel in der Zeitschrift Australian and New Zealand Journal of Obstetrics and Gynaecology, 2025. Verfasst von Sarah Long und 17 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Research Australia (NeuRA), Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Prenatal Diagnosis, Genetic Testing, Congenital Abnormalities. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Federal Government, Australian Government.
Abstract (Originalsprache)
Prenatal genomic sequencing, which can provide a significantly increased diagnostic rate for fetal structural anomaly (FSA) compared with karyotype and microarray, is not available uniformly across Australia. PreGen, a 5‐year translational research program, has identified significant barriers to implementation including access to funding, the availability of genomic testing, access to termination of pregnancy services and the availability of specialist genomic centres. A federal item number for prenatal genomic testing would increase equitable test availability and reduce delays to diagnoses by making them in pregnancy whilst removing the need for low‐yield diagnostic interventions and enabling personalised patient management and family support.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neuroscience Research Australia (NeuRA), Sydney, New South Wales, Australia.
- GenIMPACT: Centre for Economic Impacts of Genomic Medicine, Macquarie Business School, Macquarie University, Sydney, New South Wales, Australia.
- Genetics and Molecular Pathology, Centre of Cancer Biology, South Australia Pathology, Adelaide, South Australia, Australia.
- Behavioural Sciences Unit, Kids Cancer Centre, Sydney Children's Hospital, Randwick, New South Wales, Australia.
- School of Clinical Medicine, UNSW Medicine and Health, Discipline of Paediatrics, UNSW Sydney, Sydney, New South Wales, Australia.
- Feto-Maternal Unit, South Western Sydney Local Health District, Sydney, New South Wales, Australia.
ORCID-Profile: Gemma Fernihough
Förderung
- Federal Government
- Australian Government
Zitieren
APA
Long, S., Schofield, D., Kraindler, J., Vink, R., Ross, K., Hart, N., Evans, H., Wilson, A., Hyett, J., Wakefield, C. E., Kelada, L., Scott, H., Lunke, S., Wall, M., Buckley, M. F., Fernihough, G., McGillivray, G., & Roscioli, T. (2025). The PreGen Research Program: Implementing Prenatal Genomic Testing in Australia—A Commentary. Australian and New Zealand Journal of Obstetrics and Gynaecology. https://doi.org/10.1111/ajo.13936
Vancouver
Long S, Schofield D, Kraindler J, Vink R, Ross K, Hart N, et al. The PreGen Research Program: Implementing Prenatal Genomic Testing in Australia—A Commentary. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2025. doi:10.1111/ajo.13936
BibTeX
@article{Long2025,
author = {Long, Sarah and Schofield, Deborah and Kraindler, Josh and Vink, Rebecca and Ross, Kate and Hart, Natalie and Evans, Holly and Wilson, Alyssa and Hyett, Jon and Wakefield, Claire E and Kelada, Lauren and Scott, Hamish and Lunke, Sebastian and Wall, Meaghan and Buckley, Michael F and Fernihough, Gemma and McGillivray, George and Roscioli, Tony},
title = {The PreGen Research Program: Implementing Prenatal Genomic Testing in Australia—A Commentary},
journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
year = {2025},
doi = {10.1111/ajo.13936}
}
EUVIMED